| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Nagoya University |
| Information provided by: | Nagoya University |
| ClinicalTrials.gov Identifier: | NCT00408824 |
Purpose
The metabolic syndrome is a highly prevalent disorder, which causes atherosclerotic cardiovascular disease and is closely associated with insulin resistance. The alteration of the secretion of adipocytokines from accumulated visceral adipose tissue in the obese induces insulin resistance. The purpose of this study is to identify gene polymorphisms that confer susceptibility to the metabolic syndrome and to make up a new health guidance program based on genetic risk assessment. About 25% of male employees over 45 years old in a certain company are diagnosed with the metabolic syndrome in medical examination. We, the researchers at Nagoya University, will analyze gene polymorphism and various biomarkers of over 3500 company employees.
| Condition |
|
Healthy Metabolic Syndrome X Hyperlipidemia Hypertension Diabetes Mellitus |
| MedlinePlus related topics: | Diabetes High Blood Pressure Metabolic Syndrome |
| Drug Information available for: | Insulin |
| Study Type: | Observational |
| Study Design: | Natural History, Longitudinal, Case Control, Retrospective/Prospective Study |
| Official Title: | Assessment of Genetic Risk of Metabolic Syndrome in Company Employee and Making New Health Guidance Program (NGK Study) |
Eligibility
| Ages Eligible for Study: | 20 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Contacts and Locations| Contact: Kenji Yasui, MD, PhD | +81-52-788-6211 | kenji@riem.nagoya-u.ac.jp |
| Japan, Aichi | |||||
| Department of Bio-information Analysis, Research Institute of Environmental Medicine, Nagoya University | Recruiting | ||||
| Nagoya, Aichi, Japan, 464-8601 | |||||
| Contact: Kenji Yasui, MD, PhD +81-52-788-6211 kenji@riem.nagoya-u.ac.jp | |||||
| Principal Investigator: Kenji Yasui, MD, PhD | |||||
| Nagoya University |
| Study Chair: | Kenji Yasui, MD, PhD | Department of Bio-information Analysis, Research Institute of Environmental Medicine, Nagoya University |
More Information
| Study ID Numbers: | RIEM-G-3 |
| First Received: | December 6, 2006 |
| Last Updated: | September 19, 2007 |
| ClinicalTrials.gov Identifier: | NCT00408824 |
| Health Authority: | Japan: Ministry of Education, Culture, Sports, Science and Technology |
|
|
|
|
|
